Skip to main content
Premium Trial:

Request an Annual Quote

NanoCellect Raises $35M to Support Commercial Push for Second-Generation Cell Sorter

NEW YORK – Cell-sorting technologies firm NanoCellect Biomedical said Thursday that it has closed two financing rounds totaling $35 million as of this month, with plans to use the funds to accelerate its commercial growth and support new product development.

The firm's $15 million Series C round, led by Vertical Venture Partners, closed early this year. VVP was joined by existing investors including Agilent, Illumina Ventures, and FusionX Ventures; and by new investors including Yonjin Capital and Sagian Equity.

This was followed by a $20 million Series D financing led by Warburg Pincus, which closed in August. Warburg was joined by new investor, Casdin Capital, and by several existing investors including Illumina Ventures, VVP, Anzu Partners, FusionX Ventures, and Sagian Equity.

According to NanoCellect, the funds will support the launch of its second-generation Wolf G2 cell sorting system, fuel future product development, and help the company expand its commercial reach.

"The past 18 months have been challenging given the ongoing pandemic, but [we] completed the development and launch of our new Wolf G2 platform, added new international distribution partners, and nearly doubled our global installations," NanoCellect CEO Chris Neary said in a statement.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.